An Expanded Access Program of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant

APPROVED_FOR_MARKETING

Conditions studied: Graft-versus-host Disease (GVHD)

In brief

To provide ruxolitinib through an expanded access program for the treatment of graft-versus-host disease (GVHD) in United States to patients who are ineligible or unable to participate in any actively enrolling Incyte-sponsored clinical studies for ruxolitinib in the treatment of GVHD.

Key facts

Study ID

NCT03147742

Run by

Incyte Corporation

Last updated by the study team

2022-06-07

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Mayo Clinic Arizona — Phoenix, Arizona, United States
• Cancer Transplant Institute at HonorHealth — Scottsdale, Arizona, United States
• City of Hope Medical Center — Duarte, California, United States
• Scripps Clinic — La Jolla, California, United States
• Colorado Blood Cancer Institute — Denver, Colorado, United States
• Nicklaus Children's Hospital — Miami, Florida, United States
• Blood & Marrow Transplant Center — Orlando, Florida, United States
• Northwestern Memorial Hospital — Chicago, Illinois, United States
• University of Illinois Chicago — Chicago, Illinois, United States
• Indiana Blood and Marrow Transplantation — Indianapolis, Indiana, United States
• Cancer Center of Kansas — Wichita, Kansas, United States
• Massachusetts General Hospital — Boston, Massachusetts, United States
• University of Michigan Comprehensive Cancer Center — Ann Arbor, Michigan, United States
• Spectrum Health — Grand Rapids, Michigan, United States
• Mayo Clinic Minnesota — Rochester, Minnesota, United States
• Washington University School of Medicine — St Louis, Missouri, United States
• Hackensack University Medical Center — Hackensack, New Jersey, United States
• Rutgers Cancer Institute — New Brunswick, New Jersey, United States
• New Mexico Cancer Center — Albuquerque, New Mexico, United States
• Weill Cornell Medical College — New York, New York, United States
• Memorial Sloan Kettering Cancer Center — New York, New York, United States
• Cleveland Clinic — Cleveland, Ohio, United States
• Ohio State University — Columbus, Ohio, United States
• Oregon Health & Science University — Portland, Oregon, United States
• Gettysburg Cancer Center — Gettysburg, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.